LOGIN
Comparison of risedronate, alendronate, zoledronate, and ibandronate in those with low BMD
September 2016
Comparison of risedronate, alendronate, zoledronate, and ibandronate in those with low BMD
Study Type:Meta analysis
OE Level Evidence:2
Journal Level of Evidence:N/A
Clinical effectiveness of bisphosphonates for the prevention of fragility fractures: A systematic review and network meta-analysis
Bone. 2016 Aug;89:52-8Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
A total of 27 randomized controlled trials were included in this network meta-analysis investigating the comparative efficacies of bisphosphonates - including alendronate, ibandronate, risedronate, and zoledronic acid - versus placebo or control in patients with low bone mineral density. All studied drugs demonstrated significant effects on vertebral fracture incidence and bone mineral density of ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.